Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
GM

George Mark — 13 Patents

Merck: 7 patents #1,614 of 9,382Top 20%
LRLudwig Institute For Cancer Research: 5 patents #106 of 611Top 20%
SCSchering: 1 patents #1,469 of 2,442Top 65%
SRSloan Kettering Institute For Cancer Research: 1 patents #325 of 644Top 55%
TAThe United States Of America: 1 patents #67 of 521Top 15%
New York, NY: #1,469 of 20,192 inventorsTop 8%
New York: #11,463 of 115,490 inventorsTop 10%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
George Mark has been granted 13 US patents while listed as an inventor at Merck. The first was granted in 1993 and the most recent in August 2019. George Mark ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list George Mark in New York, NY, US.

Patents per Year

Patents granted per year, 1993 to 2019Bar chart with a peak of 3 patents in 1998.peak 31993: 1 patents19931998: 3 patents19982001: 1 patents20012004: 3 patents20042013: 1 patents20132015: 2 patents20152017: 1 patents20172019: 1 patents2019

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10385138 Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy Gerd Ritter, Beatrice Yin, Anne Murray, Lloyd J. Old, Kenneth O. Lloyd +4 more 2019-08-20
9701755 Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Gerd Ritter, Beatrice Yin, Anne Murray, Lloyd J. Old, Kenneth O. Lloyd +4 more 2017-07-11
9072798 Specific binding proteins and uses thereof Gerd Ritter, Anne Murray, Christoph Renner 2015-07-07
9045533 Membrane transporter NaPi2b (SCL34A2) epitope antibodies Gerd Ritter, Beatrice Yin, Anne Murray, Lloyd J. Old, Kenneth O. Lloyd +4 more 2015-06-02
8603474 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Gerd Ritter, Beatrice Yin, Anne Murray, Lloyd J. Old, Kenneth O. Lloyd +4 more 2013-12-10
6797492 Method for reducing the immunogenicity of antibody variable domains Bruce Daugherty, Eduardo A. Padlan 2004-09-28 $56,324,000
6750041 Homologous recombination antibody expression system for murine cells Gregory F. Hollis 2004-06-15 $106,630,000
6743622 Homologous recombination antibody expression system for murine cells Gregory F. Hollis 2004-06-01 $135,889,000
6280740 Formulations of recombinant papillomavirus vaccines Sunil Gupta 2001-08-28 $230,126,000
5830849 Vampire bat salivary plasminogen activators Richard A. Dixon, Stephen Gardell, Le T. Duong, Paul A. Friedman, John W. Jacobs +1 more 1998-11-03
5795754 Synthetic HPV11 virus-like particles Steven W. Ludmerer, Gregory F. Hollis, Diana Benincasa 1998-08-18 $268,253,000
5738853 Synthetic HPV11 virus-like particles Steven W. Ludmerer, Diana Benincasa 1998-04-14 $246,674,000
5189019 Antistasin derived anticoagulant protein Linda O. Palladino, Melvin Silberklang, Jwu-Sheng Tung, Simon W. Law 1993-02-23 $23,546,000